Postpartum Depression in the Covid-19 Pandemic and the Impact of Anaesthesia
NCT ID: NCT04437342
Last Updated: 2021-01-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
330 participants
OBSERVATIONAL
2020-06-30
2020-10-27
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Giving Birth During the Covid 19 Pandemia on Postnatal Women's Depression
NCT04368208
Risk Factors for Anxiety and Depression Among Pregnant Women During the COVID-19 Pandemic
NCT04377412
Post-partum Depression, Breastfeeding Adherence and Fear in COVID-19
NCT04769700
Delivery During Covid-19 Pandemic: Implications for Obstetrics, Maternal Psychopathology, and Mother-Infant Relationship
NCT04609501
Maternal Attachment and Depression Anxiety Score Evaluation in COVID-19 Positive Pregnant Women
NCT04629638
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Maternal Group
Pregnant women in labour (vaginal delivery or caesarean section) that are admitted to the hospital. Pre-labour 3 different questionnaires are administered to evaluate depression, general anxiety disorder and the association to the covid-19 pandemic. 40 days post delivery via telephone contact 2 questionnaires are administered, one in order to assess the postpartum disorder the other to assess depression.
GAD-7 (General Anxiety Disorder) scale
7 question questionnaire for assessment of General Anxiety Disorder
38 questions questionnaire
38 questions questionnaire
EPDS (Edinburgh Postnatal Depression Scale)
10 questions scale for detection of postpartum depression
PHQ-9 (Patient Health Questionnaire) Depression Scale
9 question questionnaire for assessment of depression
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
GAD-7 (General Anxiety Disorder) scale
7 question questionnaire for assessment of General Anxiety Disorder
38 questions questionnaire
38 questions questionnaire
EPDS (Edinburgh Postnatal Depression Scale)
10 questions scale for detection of postpartum depression
PHQ-9 (Patient Health Questionnaire) Depression Scale
9 question questionnaire for assessment of depression
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Drug abuse
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National and Kapodistrian University of Athens
OTHER
Alexandra Hospital, Athens, Greece
OTHER
University of Ioannina
OTHER
Larissa University Hospital
OTHER
General and Maternity Hospital of Athens Elena Venizelou
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
GEORGIA MICHA
Anaesthesiologist, MD, MSc, PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Georgia Micha, PhD
Role: PRINCIPAL_INVESTIGATOR
Elena Venizelou General and Maternity Hospital of Athens, Greece
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
"Elena Venizelou" General and Maternity Hospital of Athens
Athens, Attica, Greece
Aretaieio University Hospital
Athens, Attica, Greece
Alexandra Genaral Hospital Athens
Athens, , Greece
University of Ioannina Health Science
Ioannina, , Greece
University of Ioannina, Medical School
Ioannina, , Greece
University of Thessaly Medical School
Larissa, , Greece
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Covid-19 Postpartum depression
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.